{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:01:17Z","timestamp":1760058077093,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jemermed.2022.10.010","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T15:34:13Z","timestamp":1673537653000},"page":"111-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Can Risk Stratification Tools Be Utilized to Safely Discharge Low-Risk Febrile Neutropenic Patients from the Emergency Department?"],"prefix":"10.1016","volume":"64","author":[{"given":"Alice Y.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary M.","family":"Vilke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-3800","authenticated-orcid":false,"given":"Christopher","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jemermed.2022.10.010_bib0001","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0002","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/cncr.20983","article-title":"Linde-Zwirble WT. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy","volume":"103","author":"Caggiano","year":"2005","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.jemermed.2022.10.010_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216835","article-title":"Near-universal hospitalization of US emergency department patients with cancer and febrile neutropenia","volume":"14","author":"Baugh","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jemermed.2022.10.010_bib0004","doi-asserted-by":"crossref","first-page":"e28140","DOI":"10.1002\/pbc.28140","article-title":"Variation in hospital admission from the emergency department for children with cancer: a Pediatric Health Information System study","volume":"67","author":"Mueller","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0005","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1097\/MPH.0000000000001084","article-title":"Cost-effectiveness and improved parent and provider satisfaction with outpatient management of pediatric oncology patients, with low-risk fever and neutropenia","volume":"40","author":"Bavle","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0006","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients","volume":"18","author":"Klastersky","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0007","first-page":"5905","article-title":"Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study","volume":"29","author":"Bhardwaj","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0008","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/bjc.2011.284","article-title":"Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients","volume":"105","author":"Carmona-Bayonas","year":"2011","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.jemermed.2022.10.010_sbref0009a","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jemermed.2015.10.013","article-title":"Influenza in the Emergency Department: Vaccination, Diagnosis, and Treatment: Clinical Practice Paper Approved by American Academy of Emergency Medicine Clinical Guidelines Committee","volume":"50","author":"Abraham","year":"2016","journal-title":"J Emerg Med."},{"key":"10.1016\/j.jemermed.2022.10.010_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102922","volume":"149","author":"Zheng","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.11.013","article-title":"Risk stratification in children with cancer and febrile neutropenia: a national, prospective, multicentre validation of nine clinical decision rules","volume":"18","author":"Haeusler","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0011","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1515\/cclm-2018-0154","article-title":"Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropenia","volume":"57","author":"Garc\u00eda de Guadiana-Romualdo","year":"2019","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1016\/j.jemermed.2022.10.010_bib0012","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2019.010702","article-title":"Prognostic value of procalcitonin and lipopolysaccharide binding protein in cancer patients with chemotherapy-associated febrile neutropenia presenting to an emergency department","volume":"29","author":"Garc\u00eda de Guadiana-Romualdo","year":"2019","journal-title":"Biochem Med (Zagreb)"},{"issue":"5","key":"10.1016\/j.jemermed.2022.10.010_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197049","article-title":"Integrative omics to detect bacteremia in patients with febrile neutropenia","volume":"13","author":"Kelly","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0014","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.ajem.2019.09.016","article-title":"CISNE versus MASCC: identifying low risk febrile neutropenic patients","volume":"38","author":"Mohindra","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0015","first-page":"1609","article-title":"Home-based care of low-risk febrile neutropenia in children-an implementation study in a tertiary paediatric hospital","volume":"29","author":"Haeusler","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0016","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/COC.0000000000000498","article-title":"Prospective evaluation of multinational association of supportive care in cancer risk index score for gynecologic oncology patients with febrile neutropenia","volume":"42","author":"Gunderson","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0017","first-page":"3039","article-title":"A cohort study on protocol-based nurse-led out-patient management of post-chemotherapy low-risk febrile neutropenia","volume":"26","author":"Ying","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0018","first-page":"1465","article-title":"Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents","volume":"26","author":"Ahn","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0019","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.annemergmed.2016.11.007","article-title":"Application of the MASCC and CISNE risk-stratification scores to identify low-risk febrile neutropenic patients in the emergency department","volume":"69","author":"Coyne","year":"2017","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2192378","article-title":"Diagnostic accuracy of procalcitonin, neutrophil-to-lymphocyte ratio, and C-reactive protein in detection of bacterial infections and prediction of outcome in nonneutropenic febrile patients with lung malignancy","volume":"2020","author":"Ding","year":"2020","journal-title":"J Oncol"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0021","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/bjc.2017.154","article-title":"Predicting infectious complications in children with cancer: an external validation study","volume":"117","author":"Haeusler","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0022","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1177\/1078155219896396","article-title":"Guideline adherence for the management of emergency department patients with febrile neutropenia and no infection source: is there room for improvement?","volume":"26","author":"Jansma","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0023","first-page":"1557","article-title":"Predictive performance of the quick Sequential Organ Failure Assessment score as a screening tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia","volume":"25","author":"Kim","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0024","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jemermed.2019.09.032","article-title":"Emergency ambulatory management of low-risk febrile neutropenia: multinational association for supportive care in cancer fits-real-world experience from a UK cancer center","volume":"58","author":"Marshall","year":"2020","journal-title":"J Emerg Med"},{"issue":"7","key":"10.1016\/j.jemermed.2022.10.010_bib0025","doi-asserted-by":"crossref","first-page":"e27679","DOI":"10.1002\/pbc.27679","article-title":"Outcomes of a clinical pathway for primary outpatient management of pediatric patients with low-risk febrile neutropenia","volume":"66","author":"Paolino","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0026","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/acem.13079","article-title":"Emergency department management of patients with febrile neutropenia: guideline concordant or overly aggressive?","volume":"24","author":"Baugh","year":"2017","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0027","first-page":"2937","article-title":"A novel approach to improving ambulatory outpatient management of low risk febrile neutropenia: an Enhanced Supportive Care (ESC) clinic","volume":"26","author":"Cooksley","year":"2018","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.jemermed.2022.10.010_bib0028","first-page":"e1345","article-title":"Potential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center","volume":"4","author":"Nguyen","year":"2021","journal-title":"Cancer Rep (Hoboken)"},{"issue":"12","key":"10.1016\/j.jemermed.2022.10.010_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210019","article-title":"Validation of the Clinical Index of Stable Febrile Neutropenia (CISNE) model in febrile neutropenia patients visiting the emergency department. Can it guide emergency physicians to a reasonable decision on outpatient vs. inpatient treatment?","volume":"13","author":"Moon","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12288-016-0730-7","article-title":"Validation of MASCC score for risk stratification in patients of hematological disorders with febrile neutropenia","volume":"33","author":"Taj","year":"2017","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.jemermed.2022.10.010_bib0031","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jped.2020.05.002","article-title":"Evaluation of risk stratification strategies in pediatric patients with febrile neutropenia","volume":"97","author":"Janssens","year":"2021","journal-title":"J Pediatr (Rio J)"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467922005807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467922005807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:50:14Z","timestamp":1760028614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467922005807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0736467922005807"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2022.10.010","relation":{},"ISSN":["0736-4679"],"issn-type":[{"type":"print","value":"0736-4679"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can Risk Stratification Tools Be Utilized to Safely Discharge Low-Risk Febrile Neutropenic Patients from the Emergency Department?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2022.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}